Autopsy report · NCT00726570

Alterations of Blood Clotting With the Use of Sequential Compression Devices on the Lower Limbs

“Failed to reach the expected enrollment rates by the end of 2010”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 3 months before it stopped.
• 40 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Parma

Sponsor type

University, hospital or other

Conditions

Coagulation, Blood; Compression Devices, Intermittent Pneumatic; Postoperative Complications; Thrombelastography

Interventions

Sequential compression device therapy; Dalteparin; TEG

Participants

40

Sites

1

Countries

Italy

Trials that died the same way

• 30 Day Rehospitalization Risk in Hemodialysis Patients
  “Lack of enrollment as expected” (71% match in meaning)
• Prophylactic Phenobarbital After Neonatal Seizures
  “Inadequate rate of enrollment” (68% match in meaning)
• Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma
  “Insufficient enrollment rate” (68% match in meaning)
• A Pilot Study Assessing the Effect of Lymphaticovenous Micro-Anastomosis in the Treatment of Postmastectomy Lymphedema
  “Halted prematurely due to low enrollment” (67% match in meaning)
• Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures
  “Enrollment target not reached.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.